Renata PLC, a publicly listed pharmaceutical manufacturer,
has maintained its growth in profitability while expanding its business in
domestic and international markets. The company has recently started marketing
a new medicine in the Netherlands. Meanwhile, its earnings per share increased
by 37 percent in the first quarter (July to September) of the current 2026-27
fiscal year compared to the same period last year. Earlier, the company
announced a 55 percent cash dividend for shareholder...